Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
about
Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Metronomic treatment in immuno ...... ophosphamide and temozolomide.
@en
Metronomic treatment in immuno ...... ophosphamide and temozolomide.
@nl
type
label
Metronomic treatment in immuno ...... ophosphamide and temozolomide.
@en
Metronomic treatment in immuno ...... ophosphamide and temozolomide.
@nl
prefLabel
Metronomic treatment in immuno ...... ophosphamide and temozolomide.
@en
Metronomic treatment in immuno ...... ophosphamide and temozolomide.
@nl
P2093
P2860
P50
P356
P1433
P1476
Metronomic treatment in immuno ...... ophosphamide and temozolomide.
@en
P2093
Martí Pumarola
Nuria Arias-Ramos
Silvia Lope-Piedrafita
P2860
P356
10.1002/NBM.3748
P577
2017-06-01T00:00:00Z